| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22, 2022 | RVP Retractable Technologies Inc | Bigby Walter O Jr | Director | Sell | 10,000 | $3.76 | $37,600.00 | -11.1% | +38.5% | -49.7% | |
| Apr 21, 2022 | BLFS Biolife Solutions Inc | Schulz Marcus71 | Chief Revenue Officer | Sell | 477 | $13.94 | $6,649.38 | -1.1% | +36.7% | +46.3% | |
| Apr 21, 2022 | BLFS Biolife Solutions Inc | Aebersold Sarah60 | VP, Global Human Resources | Sell | 325 | $13.94 | $4,530.50 | -1.0% | +36.7% | +46.3% | |
| Apr 20, 2022 | STSS Sharps Technology Inc. | Crescenzo Andrew R. | Chief Financial Officer | Buy | 6,000 | $2.26 | $13,560.00 | New | -53.5% | -48.7% | |
| Apr 20, 2022 | STE Steris Plc | Zangerle John Adam54 | Sr. VP, Gen Counsel, And Sec. | Sell | 8,000 | $255.48 | $2,043,876.00 | -20.5% | -15.6% | -26.2% | |
| Apr 20, 2022 | EKSO Ekso Bionics Holdings, Inc. | Davis Scott G.61 | President &COO | Sell | 4,043 | $2.62 | $10,582.96 | -5.2% | -35.6% | -36.0% | |
| Apr 20, 2022 | BSX Boston Scientific Corp | Mirviss Jeffrey B.45 | EVP&Pres, Periph Intervent | Sell | 9,645 | $46.50 | $448,492.50 | -8.0% | -19.9% | +11.7% | |
| Apr 20, 2022 | STSS Sharps Technology Inc. | Hayes Robert Michael | Chief Executive Officer | Buy | 3,000 | $2.50 | $7,490.00 | +12.5% | -53.5% | -48.7% | |
| Apr 19, 2022 | DCTH Delcath Systems, Inc. | Rosalind Advisors, Inc. | Director | Buy | 1,600 | $6.25 | $10,000.00 | +0.4% | -38.1% | -11.4% | |
| Apr 19, 2022 | SERA Sera Prognostics, Inc. | Boniface John J.55 | Chief Scientific Officer | Sell | 2,725 | $2.08 | $5,668.00 | -3.1% | -12.8% | +53.0% | |
| Apr 19, 2022 | DCTH Delcath Systems, Inc. | Salamon Steven A J50 | Director | Buy | 1,600 | $6.25 | $10,000.00 | +0.4% | -38.1% | -11.4% | |
| Apr 19, 2022 | IRMD Iradimed Corp | Susi Roger E.53 | President, CEO And Chairman | Sell | 10,000 | $43.90 | $439,023.00 | -1.5% | -18.6% | -6.5% | |
| Apr 19, 2022 | BSX Boston Scientific Corp | Mirviss Jeffrey B.45 | EVP&Pres, Periph Intervent | Sell | 10,989 | $45.50 | $499,999.50 | -8.4% | -18.7% | +15.7% | |
| Apr 19, 2022 | CTKB Cytek Biosciences, Inc. | Yan Ming77 | Chief Technology Officer | Sell | 20,000 | $10.34 | $206,800.00 | -0.2% | +10.1% | -6.4% | |
| Apr 19, 2022 | Davidar David D54 | Director | Sell | 31,500 | $78.03 | $2,458,071.00 | -5.0% | -27.9% | -26.1% | ||
| Apr 19, 2022 | STIM Neuronetics, Inc. | Cannell Capital LLC69 | 10% Owner | Buy | 206 | $2.89 | $595.34 | - | +22.1% | -26.8% | |
| Apr 19, 2022 | TELA Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P.57 | See Footnote 2 | Buy | 8,789 | $9.83 | $86,378.00 | - | -17.0% | -4.8% | |
| Apr 18, 2022 | BLFS Biolife Solutions Inc | Rice Michael72 | CEO | Sell | 24,400 | $17.59 | $429,196.00 | -6.3% | -1.3% | +20.3% | |
| Apr 18, 2022 | BLFS Biolife Solutions Inc | Berard Todd67 | Chief Marketing Officer | Sell | 13,581 | $17.59 | $238,889.79 | -11.1% | -1.3% | +20.3% | |
| Apr 18, 2022 | MLSS Milestone Scientific Inc. | Osser Leonard87 | Director | Sell | 9,842 | $1.12 | $11,023.04 | -0.2% | -9.6% | -32.5% | |
| Apr 18, 2022 | SIBN Si-Bone, Inc. | Recupero Anthony J63 | President, Commercial Ops | Sell | 577 | $19.92 | $11,496.03 | -0.3% | -31.4% | +2.8% | |
| Apr 18, 2022 | SIBN Si-Bone, Inc. | Pisetsky Michael A68 | SVP, Ops &Adm/ Chief Legal Ofr | Sell | 349 | $19.92 | $6,953.41 | -0.3% | -31.4% | +2.8% | |
| Apr 18, 2022 | BLFS Biolife Solutions Inc | Schulz Marcus71 | Chief Revenue Officer | Sell | 286 | $17.59 | $5,030.74 | -0.7% | -1.3% | +20.3% | |
| Apr 18, 2022 | DCTH Delcath Systems, Inc. | Rosalind Advisors, Inc. | Director | Buy | 2,000 | $6.35 | $12,697.40 | +0.5% | -37.1% | -9.6% | |
| Apr 18, 2022 | NVST Envista Holdings Corp | Yu Howard H71 | Chief Financial Officer | Sell | 5,341 | $45.73 | $244,243.93 | -9.2% | -14.6% | -18.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.